Methods for treating macular degeneration with topiramate

Details Methods for treating macular degeneration with topiramate Methods for treating macular degeneration with topiramate

2005-09-27

2005-09-27

Fay, Zohreh (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S236200, C514S912000

Reexamination Certificate

active

06949518

ABSTRACT:
A method for treating macular degeneration and/or treating optic nerve degeneration of a patient comprises administering topiramate with a dosage pharmaceutically effective to suppress degeneration or induce growth of new optic nerve fibers over a sustained period.

REFERENCES:
patent: 4599353 (1986-07-01), Bito
patent: 5153192 (1992-10-01), Dean et al.
patent: 5238961 (1993-08-01), Woodward et al.
patent: 5688770 (1997-11-01), Watkins
patent: 5935933 (1999-08-01), Shank et al.
patent: 6071537 (2000-06-01), Shank
patent: 6201010 (2001-03-01), Cottrell
patent: 6319903 (2001-11-01), Carrazana et al.
patent: 6362220 (2002-03-01), Cottrell
patent: 6559293 (2003-05-01), Almarsson et al.
patent: 6696091 (2004-02-01), Thakur et al.
patent: 6699840 (2004-03-01), Almarsson et al.
C Laino “Topiramate Relieves Peripheral Neuropathy, Improves Metabolic Syndrome” Medscape Medical News 2003.
“Topiramate Effective in Preventing Migranes”, Reuters Health Information 2004.

Affiliated with

Also associated with

Rating

Methods for treating macular degeneration with topiramate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating macular degeneration with topiramate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating macular degeneration with topiramate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3430681